Skip to content

Author

Nawal Al-Hoshani

We have 7 of 69 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Design, synthesis, biological evaluation and computational investigation of Thiadiazole Benzimidazole derivatives bearing a Chlorophyrimidine pharmacophore as potent CLK2 inhibitors and anticancer agents.

Cdc2-like kinase 2 (CLK2) has emerged as an attractive anticancer therapeutic target because of its crucial role in pre-mRNA splicing and tumor growth. Here, we designed and synthesized a novel series of thiadiazole-based benzimidazole derivatives 15a-l incorporating chloropyrimidine pharmacophore and evaluated for CLK...

T. Aziz, Rafaqat Hussain, H. Sarfraz et al. · 0 citations
Oct 2026

Design, synthesis, and biological evaluation of pyrimidine linked fused thiazole–isoxazole conjugates as dual cholinesterase inhibitors for Alzheimer’s disease

Pyrimidine-clubbed thiazolo[4,5-c]isoxazole is established as a mechanistically grounded scaffold with translational potential for next-generation anti-Alzheimer therapeutics and electronic reactivity and drug-likeness of lead compounds are confirmed.

Y. Khan, Mujeeb Ul Naeem, Syeda Farwa Naqvi et al. · 0 citations
Oct 2026

Computationally Guided Design and Biological Evaluation of New Benzoxazole Bridged thiazole based 1,3-Oxazole Conjugates as Potential Anti-Alzheimer's Agents: Molecular Docking, DFT and sADMET Studies

Findings identify benzoxazole-oxazole linked thiazole molecular hybrids as promising lead scaffolds for the development of next-generation multifunctional therapeutics for the treatment of Alzheimer's disease.

Syeda Farwa Naqvi, H. Sarfraz, Abdul Rehman et al. · 0 citations
Open access Oct 2026

Integrated Transcriptomic and Network Analysis Identifies Diagnostic and Immune-Associated Hub Genes in Urothelial Carcinoma

Background: Urothelial carcinoma exhibits molecular heterogeneity, high recurrence, and progression rates, and is poorly diagnosed and treated. Transcriptomic and systems-biology analyses can detect dysregulated genes, signaling pathways, and interactions of immune cells. Proposed biomarkers, however, have not been val...

Shaza N. Alkhatib, A. Binsaleh, N. Al-Hoshani et al. · 0 citations
Open access Sep 2026

A comparative study of machine learning models in QSPR analysis of antihypertensive drug compounds

This study explores the quantitative structure–property relationship models to predict significant properties of antihypertensive drug molecules using machine learning methods and considers various molecular properties such as molecular weight, heavy atom count, molecular complexity, molar refractivity, polarizability,...

M. Arockiaraj, Vinibala Shanmugham, H. M. Alshanbari et al. · 0 citations
Oct 2026

Integrating in vitro and in silico correlation of thiazole-based carboxamide derivatives as promising SARS-CoV-2 papain-like protease inhibitors: a versatile approach for COVID-19 therapy

Experimental and computational findings identify thiazole-based carboxamide derivatives, particularly compounds (8) and (6), as promising candidates for the development of potent SARS-CoV-2 PLpro inhibitors.

Imran Khan, Rafaqat Hussain, H. Sarfraz et al. · 0 citations
Open access Sep 2026

Integrative Multi-Omics Analysis Reveals Host Regulatory and Immune Networks with Inferred Dysbiosis Relevance in Colorectal Cancer

The findings provide a system-level framework describing the associations between dysbiosis-relevant host pathways, CRC-related regulatory networks, and immune responses and represent hypothesis-generating host candidates for further mechanistic and clinical validation.

Huda Altoukhi, Nawal H. Siddig, N. Al-Hoshani et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.